Woodline Partners’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-104,831
| Closed | -$1.96M | – | 650 |
|
|
2024
Q1 | $1.96M | Buy |
+104,831
| New | +$1.96M | 0.02% | 422 |
|
|
2022
Q2 | – | Sell |
-77,866
| Closed | -$2.58M | – | 874 |
|
|
2022
Q1 | $2.58M | Buy |
+77,866
| New | +$2.58M | 0.04% | 343 |
|
|
2021
Q4 | – | Sell |
-34,813
| Closed | -$1.54M | – | 774 |
|
|
2021
Q3 | $1.54M | Buy |
+34,813
| New | +$1.54M | 0.03% | 442 |
|
|
2021
Q2 | – | Sell |
-234,434
| Closed | -$17.5M | – | 626 |
|
|
2021
Q1 | $17.5M | Buy |
234,434
+49,876
| +27% | +$3.73M | 0.39% | 75 |
|
|
2020
Q4 | $16M | Sell |
184,558
-576
| -0.3% | -$49.8K | 0.42% | 76 |
|
|
2020
Q3 | $11.3M | Sell |
185,134
-102,809
| -36% | -$6.28M | 0.37% | 80 |
|
|
2020
Q2 | $12M | Buy |
287,943
+129,116
| +81% | +$5.37M | 0.47% | 64 |
|
|
2020
Q1 | $4.56M | Buy |
158,827
+138,535
| +683% | +$3.98M | 0.33% | 90 |
|
|
2019
Q4 | $1.47M | Buy |
+20,292
| New | +$1.47M | 0.06% | 103 |
|